Multiple markets retreat amid more COVID-19 restrictions - Wednesday Review, November 18

Multiple markets retreat amid more COVID-19 restrictions - Wednesday Review, November 18

Yet again, the markets are under COVID’s spell

The US

The fact that Pfizer has a vaccine which is 95% effective in preventing COVID-19 infections didn’t impress the markets. Investors focused on the new restrictions that could be enforced to curb the number of infections, threatening the economic rebound. USA30 fell 1.16%, while USA500 lost 1.17%. TECH100 closed 0.82% lower.

Crude oil settled up 1% at $41.82 a barrel.

Gold traded at $1,880.15 per ounce.

The Dollar Index inched 0.15% lower at 92.263.

Asia and Australia

The benchmarks ended the trading session mixedly. Some markets were driven by the better-than-expected exports, which could make the chances for a fiscal stimulus from the Bank of Japan slimmer. On the other hand, markets closed higher for the third consecutive day and even reached new highs. The boost came from the gains reported in the automotive sector and Moderna’s potential COVID-19 vaccine.

Japan225 lost 1.10%.

HongKong45 closed 0.49% higher.

Down under, Australia200 finished up 0.51%, reaching a high unseen since March 3.

Europe

The fact that more and more countries are going back into lockdown made investors lose hope in a post-pandemic economic rebound. Germany30 and France40 lost 0.1%. UK100 dropped 0.3%.

Brent oil traded at $44.34 after it gained 1.3%.

EUR/USD went up 0.2% at 1.1879.

EUR/GBP lost 0.33%, trading at 0.8922.

Sources: reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com

JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.